• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

COA Submits Formal Comments on Medicare International Pricing Proposal

Article

The Community Oncology Alliance (COA) has submitted formal comments to CMS regarding the Medicare Program International Pricing Index Model for Medicare Part B Drugs pre-poposed rule

The Community Oncology Alliance (COA) has submitted formal comments to CMS regarding the Medicare Program International Pricing Index Model for Medicare Part B Drugs pre-poposed rule. They write that despite their concern over rising drug prices and high costs of cancer care, they do not support a mandatory, national experiment on patient care. They add that they have serious concerns about the impact of the model on the care received by patients with cancer, the impacticality of its design, and its legaltiy. Based on these concerns, COA urges CMS to not move foward with the proposal.

Read the full comment letter.

Related Videos
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Rakendu Rajendran, MBBS, Virtua Health
Dr Brian Mulherin
Dr Brian Mulherin
Lindsey Valenzuela, PharmD, APh, BCACP - screenshot by AJMC
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Related Content
Healthcare.gov marketplace exchange - Tada Images - stock.adobe.com.jpeg

5 Consequences If ACA Premium Subsidies End in 2026

October 31st 2025
Article

As open enrollment begins November 1, 2025, millions are signing up under enhanced subsidies that are set to expire at the end of this year.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

October 30th 2025
Podcast

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

Lawmaking | Image Credit: Polonio Video - stock.adobe.com

New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access

October 30th 2025
Article

PBM legislation is rising nationwide, which experts emphasize could increase costs and hinder patient care.

Read More

Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN

Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN

October 21st 2025
Podcast

Melanie T. Turk, PhD, RN, discusses her study on nationwide challenges program suppliers face in implementing the Medicare Diabetes Prevention Program (MDPP).

Listen

HIV treatment | Image Credit: alexskopje - stock.adobe.com

Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders

October 29th 2025
Article

The antiretroviral (ART) regimen Biktarvy showed higher 1-year ART persistence and lower switch rates among people with HIV.

Read More

Paul Ryan and Susan Cantrell | Image Credit: Brooke McCormick

Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown

October 28th 2025
Article

In the midst of a government shutdown, former House Speaker Paul Ryan urges clear policies, AI innovation, and patient-focused solutions to build a sustainable US health care system.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.